Neimeth International Pharmaceuticals Plc (NGX:NEIMETH)

NGX:NEIMETH Ratios and Metrics

Market cap in millions NGN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021
Period Ending	Oct 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Sep 30, 2022	Sep 30, 2021
Market Capitalization	27,348	9,785	8,290	2,716	2,659	3,324
Market Cap Growth	220.00%	18.04%	205.24%	2.14%	-20.00%	-5.41%
Enterprise Value	30,664	11,901	9,264	5,237	4,683	5,412
Last Close Price	6.40	2.29	1.94	1.43	1.40	1.68
PE Ratio	-	-	-	-	-	12.28
PS Ratio	4.77	2.18	3.75	0.93	0.98	1.09
PB Ratio	14.61	5.92	3.27	3.49	2.43	2.35
P/TBV Ratio	14.73	5.99	3.27	3.49	2.43	2.35
P/FCF Ratio	69.61	-	-	-	-	1693.09
P/OCF Ratio	31.70	24.70	-	20.49	-	9.61
EV/Sales Ratio	5.34	2.65	4.19	1.79	1.73	1.78
EV/EBITDA Ratio	12.75	6.07	21.81	54.54	49.41	8.47
EV/EBIT Ratio	13.54	6.50	31.01	-	-	9.86
EV/FCF Ratio	78.05	-	-	-	-	2756.94
Debt / Equity Ratio	2.73	3.26	1.73	4.68	3.05	2.15
Debt / EBITDA Ratio	2.13	2.74	10.33	35.20	35.15	4.64
Debt / FCF Ratio	13.01	-	-	-	-	1551.72
Asset Turnover	0.52	0.41	0.27	-	0.43	0.48
Inventory Turnover	1.06	1.19	0.79	-	1.02	1.12
Quick Ratio	0.28	0.35	0.45	0.48	0.63	1.53
Current Ratio	0.62	0.58	0.76	1.00	1.24	2.28
Return on Equity (ROE)	-48.82%	-42.27%	-108.42%	-	-8.74%	20.13%
Return on Assets (ROA)	12.88%	10.33%	2.24%	-	-0.24%	5.41%
Return on Capital (ROIC)	22.02%	16.40%	3.29%	-	-0.35%	7.60%
Return on Capital Employed (ROCE)	95.60%	85.50%	9.80%	-	-	13.20%
Earnings Yield	-3.16%	-9.05%	-21.68%	-11.97%	-4.12%	8.14%
FCF Yield	1.44%	-3.13%	-20.62%	-41.87%	-45.31%	0.06%
Dividend Yield	-	-	-	-	-	4.17%
Payout Ratio	-	-	-	-	-	45.62%
Buyback Yield / Dilution	-7.49%	-	-125.00%	-	-	-
Total Shareholder Return	-	-	-125.00%	-	-	4.17%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.